Goldman Sachs’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$535K Buy
139,614
+15,249
+12% +$58.4K ﹤0.01% 4224
2025
Q1
$715K Sell
124,365
-115,969
-48% -$667K ﹤0.01% 4034
2024
Q4
$1.2M Buy
240,334
+95,506
+66% +$477K ﹤0.01% 3796
2024
Q3
$781K Buy
144,828
+39,901
+38% +$215K ﹤0.01% 3895
2024
Q2
$347K Buy
104,927
+13,210
+14% +$43.7K ﹤0.01% 4132
2024
Q1
$300K Sell
91,717
-55,763
-38% -$182K ﹤0.01% 4196
2023
Q4
$518K Sell
147,480
-21,203
-13% -$74.4K ﹤0.01% 3929
2023
Q3
$1.13M Sell
168,683
-28,753
-15% -$192K ﹤0.01% 3459
2023
Q2
$1.66M Sell
197,436
-89,807
-31% -$753K ﹤0.01% 3314
2023
Q1
$2.85M Buy
287,243
+263,493
+1,109% +$2.62M ﹤0.01% 2960
2022
Q4
$165K Sell
23,750
-164,557
-87% -$1.15M ﹤0.01% 4559
2022
Q3
$1.01M Sell
188,307
-996,277
-84% -$5.32M ﹤0.01% 3817
2022
Q2
$4.73M Sell
1,184,584
-206,434
-15% -$824K ﹤0.01% 2698
2022
Q1
$6.18M Buy
1,391,018
+1,288,353
+1,255% +$5.73M ﹤0.01% 2636
2021
Q4
$410K Sell
102,665
-19,390
-16% -$77.4K ﹤0.01% 4625
2021
Q3
$1.07M Sell
122,055
-885,564
-88% -$7.78M ﹤0.01% 3921
2021
Q2
$11.4M Buy
1,007,619
+931,972
+1,232% +$10.6M ﹤0.01% 2155
2021
Q1
$899K Buy
75,647
+32,712
+76% +$389K ﹤0.01% 3985
2020
Q4
$295K Buy
42,935
+13,374
+45% +$91.9K ﹤0.01% 4085
2020
Q3
$219K Sell
29,561
-7,512
-20% -$55.7K ﹤0.01% 4028
2020
Q2
$155K Buy
37,073
+9,124
+33% +$38.1K ﹤0.01% 4070
2020
Q1
$69K Sell
27,949
-71,124
-72% -$176K ﹤0.01% 4221
2019
Q4
$575K Buy
99,073
+18,817
+23% +$109K ﹤0.01% 3580
2019
Q3
$423K Buy
80,256
+64,019
+394% +$337K ﹤0.01% 3657
2019
Q2
$97K Buy
16,237
+3,864
+31% +$23.1K ﹤0.01% 3999
2019
Q1
$112K Sell
12,373
-6,166
-33% -$55.8K ﹤0.01% 4000
2018
Q4
$154K Sell
18,539
-8,884
-32% -$73.8K ﹤0.01% 3803
2018
Q3
$378K Buy
+27,423
New +$378K ﹤0.01% 3561
2018
Q2
Sell
-15,567
Closed -$117K 4154
2018
Q1
$117K Buy
+15,567
New +$117K ﹤0.01% 3985